AQST Key Financial Ratios - Aquestive Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	7.19	—	-59.22%	138.24%
2026-03-31	4.1	—	-48.83%	202.36%
2025-12-31	3.14	—	-52.23%	248.90%
2025-09-30	5.93	—	-42.17%	1678.73%
2025-06-30	3.53	—	-69.42%	89.60%
2025-03-31	4.87	—	-53.05%	89.02%
2024-12-31	4.68	—	-43.52%	73.37%
2024-09-30	6.37	—	-32.01%	77.48%
2024-06-30	7.49	—	-21.87%	72.49%
2024-03-31	6.28	—	-22.21%	79.24%
2023-12-31	2.24	—	-13.71%	7.39%
2023-09-30	1.76	—	-20.37%	11.77%
2023-06-30	1.03	—	-39.67%	21.20%
2023-03-31	1.08	—	-54.05%	30.32%
2022-12-31	1.01	—	-95.34%	45.89%
2022-09-30	1.04	—	-136.95%	65.85%
2022-06-30	1.47	—	-129.68%	75.78%
2022-03-31	1.76	—	-122.22%	74.17%
2021-12-31	2.15	—	-113.79%	85.88%
2021-09-30	2.01	—	-94.90%	102.68%
2021-06-30	2.21	—	-95.64%	118.95%
2021-03-31	2.22	—	-87.08%	104.11%
2020-12-31	2.11	—	-88.71%	115.02%
2020-09-30	1.72	—	-95.30%	131.58%
2020-06-30	2.95	—	-78.54%	233.36%
2020-03-31	3.33	—	-105.53%	326.71%
2019-12-31	3.68	—	-84.41%	1082.10%
2019-09-30	1.9	—	-138.38%	196.04%
2019-06-30	1.59	—	-127.32%	260.29%
2019-03-31	1.89	—	-117.98%	1324.32%
2018-12-31	2.25	—	-70.67%	-608.89%
2018-09-30	3.63	—	-63.85%	-245.15%
2018-06-30	1.14	—	-85.30%	87.25%
2018-03-31	—	—	—	15.12%
2017-12-31	1.83	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	3.14	—	-52.23%	248.90%
2024-12-31	4.68	—	-43.52%	73.37%
2023-12-31	2.24	—	-13.71%	7.39%
2022-12-31	1.01	—	-95.34%	45.89%
2021-12-31	2.15	—	-113.79%	85.88%
2020-12-31	2.11	—	-88.71%	115.02%
2019-12-31	3.68	—	-84.41%	1082.10%
2018-12-31	2.25	—	-70.67%	-608.89%
2017-12-31	1.83	—	-20.74%	33.75%